Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Immunic Inc. | 6 | 3 | 1 | 3 | €1.15 | €5.48 | 378.760% |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €69.44 | €140.00 | 101.613% |
| Cellectar BioSciences Inc. | 7 | 9 | 2 | 1 | €2.84 | €10.55 | 271.331% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 3 | 1 | €4.70 | €12.80 | 172.372% |
| Akebia Therapeutics Inc. | 8 | 3 | 2 | 1 | €1.25 | €3.60 | 188.389% |
| AbbVie Inc. | 18 | 1 | 1 | 1 | €149.26 | €175.79 | 17.773% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €75.64 | €85.68 | 13.279% |
| Insmed Inc. | 13 | 1 | 3 | 1 | €23.20 | €44.01 | 89.684% |
| Molina Healthcare | 11 | 1 | 1 | 1 | €319.90 | €359.93 | 12.515% |
| Agilent Technologies Inc. | 17 | 3 | 1 | 1 | €127.08 | €133.66 | 5.178% |
| Universal Health Services B | 9 | 3 | 2 | 1 | €154.00 | €159.70 | 3.704% |
| Zoetis Inc. A | 20 | 1 | 3 | 1 | €148.06 | €201.64 | 36.185% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €15.63 | €28.17 | 80.216% |
| Adaptimmune Therapeutics PLC ADR | 1 | 1 | 0 | 1 | €1.00 | €1.50 | 50.000% |
| Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 6 | 1 | €825.20 | €957.22 | 15.999% |
| Addus Homecare Corp. | 12 | 1 | 0 | 1 | €87.00 | €97.00 | 11.494% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €10.87 | €22.78 | 109.621% |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €10.60 | €21.39 | 101.821% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.50 | - | - |
| Dentsply Sirona Inc. | 10 | 0 | 0 | 0 | €28.57 | €38.55 | 34.938% |
| Boston Scientific | 46 | 0 | 13 | 0 | €68.50 | €73.05 | 6.638% |
| Rewalk Robotics Ltd. | 1 | 12 | 0 | 0 | €5.00 | - | - |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.30 | €421.61 | 16.049% |
| Maternus-Kliniken AG | 1 | 0 | 0 | 0 | €1.81 | €1.65 | -8.840% |